Single-cell sequencing to quantify genomic integrity in cancer

Area of Science:

• Oncology
• Genomics
• Biotechnology

Background:

• Single-cell DNA sequencing (sc-seq) is a rapidly advancing field in cancer research.
• Decreasing sequencing costs and improved techniques are driving momentum in sc-seq research.
• Understanding cancer at the single-cell level is crucial for improving patient care.

Purpose of the Study:

• To provide an overview of recent advancements in sc-seq for cancer.
• To discuss the contribution of sc-seq to improved cancer patient care.
• To explore future perspectives of sc-seq in cancer diagnosis and treatment.

Main Methods:

• Review of recent studies utilizing single-cell DNA sequencing in cancer.
• Analysis of sc-seq applications in studying primary tumors, metastases, and circulating tumor cells.
• Examination of sc-seq's role in identifying inter- and intra-tumor heterogeneity.

Main Results:

• Sc-seq enables the study of individual cancer cell genomes, revealing heterogeneity undetectable by other methods.
• Studies show sc-seq data is valuable for cancer prognosis and predicting treatment response.
• Circulating tumor cells analyzed by sc-seq offer potential for therapy monitoring.

Conclusions:

• Sc-seq significantly enhances the understanding of cancer's genomic landscape.
• This technology is pivotal for developing personalized cancer treatments.
• Future applications include real-time therapy monitoring and precision oncology.